Results 191 to 200 of about 1,169,724 (211)

Erythropoietin modulates hepatic inflammation, glucose homeostasis, and soluble epoxide hydrolase and epoxides in high‐fat diet‐induced obese mice

open access: yesFEBS Open Bio, EarlyView.
Erythropoietin administration suppresses hepatic soluble epoxide hydrolase (sEH) expression, leading to increased CYP‐derived epoxides. This is associated with a shift in hepatic macrophage polarization characterized by reduced M1 markers and increased M2 markers, along with reduced hepatic inflammation, suppressed hepatic lipogenesis, and attenuated ...
Takeshi Goda   +12 more
wiley   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong   +2 more
exaly  

Screening, evaluation, and management of cancer‐related fatigue: Ready for implementation to practice?

Ca-A Cancer Journal for Clinicians, 2015
Ann M Berger, William F Pirl
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

Recent progress in the treatment and prevention of cancer‐related lymphedema

Ca-A Cancer Journal for Clinicians, 2015
Simona F Shaitelman   +2 more
exaly  

Chemotherapy-Related Nausea and Vomiting: Etiology and Management

Ca-A Cancer Journal for Clinicians, 1989
Gary R Morrow
exaly  

Home - About - Disclaimer - Privacy